ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.
ETFOptimize | HOME
Close Window
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ACCESSWIRE to Exhibit at the Pharma PR & Communications Summit

By: ACCESSWIRE

RALEIGH, NC / ACCESSWIRE / March 30, 2023 / ACCESSWIRE, a newswire service standout that provides regional, national and global news to thousands of clients worldwide is set to exhibit at the Pharma PR & Communications Summit (Pharma PR West) from Monday, April 3 through Tuesday, April 4.

ACCESSWIRE, Wednesday, March 29, 2023, Press release picture

This event will take place at the Hard Rock Hotel in San Diego, CA and as an exhibitor, ACCESSWIRE will share its expertise and experience in helping pharmaceutical, biotechnology, and medical device companies communicate their news to stakeholders, investors, media outlets and the public.

"With so much pivotal news to share in the healthcare industry, consistent and strategic press release distribution is key for companies to unlock their potential and ensure their stories reach a vast audience," said Jennifer Hammers, Executive Vice President of Sales & Marketing at Issuer Direct. "We're excited to attend Pharma PR West to meet with attendees and share with them how our industry-leading press release distribution services can help them achieve maximum distribution and global views."

ACCESSWIRE, an Issuer Direct company, is one of the top newswires in the industry and offers global distribution, predictable flat-fee pricing, and top-tier customer service that's been recognized by numerous G2 badges including, "Easiest To Do Business With," "Best Relationship," "Most Implementable" and more.

If you'd like to set up a private meeting with our team during Pharma PR West, click here.

###

About ACCESSWIRE/Issuer Direct Corporation

Issuer Direct is a leading communications company, providing solutions for both Public Relations and Investor Relations Professionals for over 16 years. Our comprehensive solutions are used by thousands of customers from emerging startups to multi-billion-dollar global brands, ensuring their most important moments are reaching the right audiences, via our industry-leading newswire, IR website solutions, events technology, and compliance solutions. For more information, please visit www.issuerdirect.com.

Issuer Direct Corporation Media Contacts:

Brian R. Balbirnie
+1 919-481-4000
brian.balbirnie@issuerdirect.com

James Carbonara
1+ (646)-755-7412
james@haydenir.com

SOURCE: ACCESSWIRE



View source version on accesswire.com:
https://www.accesswire.com/746427/ACCESSWIRE-to-Exhibit-at-the-Pharma-PR-Communications-Summit

Recent Quotes

View More
Symbol Price Change (%)
AMZN  231.31
+0.31 (0.13%)
AAPL  247.65
+0.95 (0.39%)
AMD  249.80
+17.88 (7.71%)
BAC  52.07
-0.03 (-0.06%)
GOOG  328.38
+6.22 (1.93%)
META  612.96
+8.84 (1.46%)
MSFT  444.11
-10.41 (-2.29%)
NVDA  183.32
+5.25 (2.95%)
ORCL  173.88
-6.04 (-3.36%)
TSLA  431.44
+12.19 (2.91%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.


 
IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.